I wonder how the people who sold at 55 cents on March 9 (after the Hep-C results) are feeling now, seeing the stock at $20.
I was hoping that IMMU would open over 7 for a nice short. Their drug for lupus isn't even on the same plane as Benlysta.... Nice day trading in bio's at this time.
Watch your eyes out for Anthera pharma. It's currently privately held, but if it goes public, buy it.